Literature DB >> 33407635

Analysis of influencing factors of viral load in patients with high-risk human papillomavirus.

Xuerong Lu1, Tiantian Wang1, Youzhong Zhang2, Yuzhen Liu3.   

Abstract

BACKGROUND: High-risk human papillomavirus (HR-HPV) load is thought to be influenced by many factors, and the relationship between viral load and the degree of cervical lesion is controversial. This study explored the possible influencing factors of HR-HPV viral load in the uterine cervix.
METHODS: A total of 605 women who needed colposcopic evaluation for abnormal cervical screening at the Affiliated Hospital of Weifang Medical University, China, between November 2017 and September 2018 were enrolled. Cervical specimens were collected from the endo- and ectocervix separately using two different cervical brushes. The hybrid capture II test was used to measure HR-HPV load. Age, histological severity, number of viral types, and area and location of cervical lesions were recorded. The correlations between viral load and influencing factors were analysed using univariate and multivariate analyses.
RESULTS: HR-HPV load was positively correlated with age, histological severity, multiple HPV types and area of cervical lesions (P < 0.05). Viral load with the combination of endo- and ectocervical sampling was significantly higher than simple endocervical sampling (P < 0.001). Multivariate analysis showed that age, multiple HPV types and area of cervical lesions were independent factors for HR-HPV load with a combination of endo- and ectocervical sampling (P < 0.05). However, only age and area of cervical lesions were independent factors for viral load with simple endocervical sampling (P < 0.05). No significant association was found between viral load and lesion severity in multivariate analysis (P > 0.05).
CONCLUSION: HR-HPV load is influenced by age, histological severity, multiple viral types, area of cervical lesion and sampling methods. Age and area of cervical lesions are independent factors for viral load.

Entities:  

Keywords:  Cervical intraepithelial lesion; Human papillomavirus; Influential factor; Viral load

Year:  2021        PMID: 33407635     DOI: 10.1186/s12985-020-01474-z

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


  23 in total

1.  The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.

Authors:  X Zhao; Q Wu; X Wang; Y Fu; X Zhang; X Tian; B Cheng; B Lu; X Yu; S Lan; W Lu; D Ma; X Cheng; X Xie
Journal:  Clin Microbiol Infect       Date:  2018-03-05       Impact factor: 8.067

Review 2.  Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?

Authors:  M Pett; N Coleman
Journal:  J Pathol       Date:  2007-08       Impact factor: 7.996

3.  Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.

Authors:  Warner K Huh; Kevin A Ault; David Chelmow; Diane D Davey; Robert A Goulart; Francisco A R Garcia; Walter K Kinney; L Stewart Massad; Edward J Mayeaux; Debbie Saslow; Mark Schiffman; Nicolas Wentzensen; Herschel W Lawson; Mark H Einstein
Journal:  Obstet Gynecol       Date:  2015-02       Impact factor: 7.661

4.  Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening.

Authors:  Hongxue Luo; Jerome L Belinson; Hui Du; Zhihong Liu; Lijie Zhang; Chun Wang; Xinfeng Qu; Robert G Pretorius; Ruifang Wu
Journal:  J Low Genit Tract Dis       Date:  2017-01       Impact factor: 1.925

5.  Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.

Authors:  Li Dong; Margaret Z Wang; Xue-Lian Zhao; Rui-Mei Feng; Shang-Ying Hu; Qian Zhang; Jennifer S Smith; You-Lin Qiao; Fang-Hui Zhao
Journal:  Gynecol Oncol       Date:  2017-11-21       Impact factor: 5.482

6.  Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study.

Authors:  Leticia Torres-Ibarra; Eduardo Lazcano-Ponce; Eduardo L Franco; Jack Cuzick; Mauricio Hernández-Ávila; Attila Lorincz; Berenice Rivera; Paula Ramírez; Indira Mendiola-Pastrana; Samantha E Rudolph; Leith León-Maldonado; Rubí Hernández; Elizabeth Barrios; Patti Gravitt; Anna Barbara Moscicki; Kathleen M Schmeler; Yvonne N Flores; Pablo Méndez-Hernández; Jorge Salmerón
Journal:  Salud Publica Mex       Date:  2016-04

7.  Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.

Authors:  Véronique Dalstein; Didier Riethmuller; Jean-Luc Prétet; Karine Le Bail Carval; Jean-Loup Sautière; Jean-Pierre Carbillet; Bernadette Kantelip; Jean-Patrick Schaal; Christiane Mougin
Journal:  Int J Cancer       Date:  2003-09-01       Impact factor: 7.396

8.  Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study.

Authors:  Susanne K Kjaer; Adriaan J C van den Brule; Gerson Paull; Edith I Svare; Mark E Sherman; Birthe L Thomsen; Mette Suntum; Johannes E Bock; Paul A Poll; Chris J L M Meijer
Journal:  BMJ       Date:  2002-09-14

Review 9.  Pathogenesis of human papillomavirus-associated mucosal disease.

Authors:  Ian J Groves; Nicholas Coleman
Journal:  J Pathol       Date:  2015-01-20       Impact factor: 7.996

10.  The DNA load of six high-risk human papillomavirus types and its association with cervical lesions.

Authors:  Luisa Del Río-Ospina; Sara Cecilia Soto-De León; Milena Camargo; Darwin Andrés Moreno-Pérez; Ricardo Sánchez; Antonio Pérez-Prados; Manuel Elkin Patarroyo; Manuel Alfonso Patarroyo
Journal:  BMC Cancer       Date:  2015-03-05       Impact factor: 4.430

View more
  1 in total

1.  Targeted Next Generation Sequencing for Human Papillomavirus Genotyping in Cervical Liquid-Based Cytology Samples.

Authors:  Karoline Andersen; Kasper Holm; Mette Tranberg; Cecilie Lebech Pedersen; Sara Bønløkke; Torben Steiniche; Berit Andersen; Magnus Stougaard
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.